Stevanato Group S.p.A. (STVN)
NYSE: STVN · Real-Time Price · USD
20.56
-0.78 (-3.66%)
Dec 20, 2024, 4:00 PM EST - Market closed
Company Description
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.
The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines.
The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A.
is a subsidiary of Stevanato Holding S.R.L.
Stevanato Group S.p.A.
Country | Italy |
Founded | 1949 |
IPO Date | Jul 16, 2021 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
Employees | 5,634 |
CEO | Franco Stevanato |
Contact Details
Address: Via Molinella, 17 Piombino Dese, PD 35017 Italy | |
Phone | 39 04 99 31 811 |
Website | stevanatogroup.com |
Stock Details
Ticker Symbol | STVN |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | EUR |
IPO Price | $21.00 |
CIK Code | 0001849853 |
CUSIP Number | T9224W109 |
ISIN Number | IT0005452658 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Franco Stevanato | Chief Executive Officer and Executive Chairman |
Marco Dal Lago | Chief Financial Officer |
Ugo Gay | Chief Operations Officer |
Lisa Miles | Chief Communication Officer and Senior Vice President of Investor Relations |
Paolo De Fabritiis | Chief Human Resources Officer |
Mauro Stocchi | Chief Business Officer |
Riccardo Butta | President of Americas |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 14, 2024 | SCHEDULE 13G | Filing |
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 14, 2024 | 6-K | Report of foreign issuer |
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Nov 14, 2024 | SCHEDULE 13G | Filing |
Nov 8, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Nov 5, 2024 | 6-K | Report of foreign issuer |
Nov 5, 2024 | 6-K | Report of foreign issuer |
Nov 5, 2024 | 6-K | Report of foreign issuer |